Mutual Funds increased holding by up to 800 basis points in Clean Science and Technology, Sai Life Sciences and Cohance Lifesciences in September quarter. Here's a technical outlook on these 3 stocks.
Cohance Lifesciences shares fell over 10% to a 52-week low after MD V Prasada Raju resigned. The pharma firm also faces USFDA "Official Action Indicated" status for its Hyderabad facility
IndusInd Bank, PG Electroplast, Five-Star Business, Cohance Lifesciences and Praj Industries have shed 20% in the last 7 months, while the Nifty and Nifty 500 have rallied up to 18%, shows data.
Cohance Lifesciences shares fell the most since August 14, after about 8.9 per cent stake changed hands on the NSE
Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators; check more details